Rafael Segal

Medicine & Life Sciences

1. Systemic Lupus Erythematosus 100%
2. Methotrexate 85%
3. Rheumatoid Arthritis 80%
4. Cytokines 37%
5. Autoantibodies 27%
6. Jews 24%
7. Interleukin-1 24%
8. DNA 22%
9. Familial erythema nodosum 21%
10. Complementarity Determining Regions 20%
11. Sjogren's Syndrome 20%
12. Monoclonal Antibodies 18%
13. Geriatrics 18%
14. edratide 18%
15. Pharmacokinetics 17%
16. Antinuclear Antibodies 17%
17. Immunization 15%
18. Oral Administration 15%
19. T-Lymphocytes 14%
20. (T,G)-A-L 14%
21. Haplotypes 13%
22. Roxithromycin 13%
23. Peptides 13%
24. Frail Elderly 13%
25. Helper-Inducer T-Lymphocytes 12%
26. Antiphospholipid Syndrome 12%
27. Common Variable Immunodeficiency 12%
28. Erythema Nodosum 12%
29. Hydroxychloroquine 11%
30. HLA-B27 Antigen 11%
31. Antigen-Antibody Complex 11%
32. Immunogenetics 11%
33. Sulfasalazine 11%
34. Severe Combined Immunodeficiency 11%
35. Pharmaceutical Preparations 11%
36. Antiphospholipid Antibodies 11%
37. Blood Sedimentation 11%
38. Acute-Phase Reaction 11%
39. Minocycline 11%
40. In Vitro Techniques 10%
41. Interleukin-2 10%
42. Hemiplegia 10%
43. Interleukin-10 10%
44. Psoriatic Arthritis 10%
45. Collagen Type III 10%
46. Leucovorin 10%
47. Regulatory T-Lymphocytes 10%
48. Cimetidine 10%
49. Th2 Cells 10%
50. Collagen Type II 10%